XRCC1 and esophageal cancer: Studies have shown that esophageal cancer patients with negative XRCC1 protein expression have slightly higher responses to radiation than those with positive expression, suggesting that patients without XRCC1 protein expression may receive a superior benefit from radiotherapy to some extent.23